Connexin-43 prevents hematopoietic stem cell senescence through transfer of reactive oxygen species to bone marrow stromal cells
Eri Ishikawa(Shizuoka City Hospital), José A. Cancelas(Harvard University), Susan Dunn(University of Cincinnati), Luis C. Barrio(Hospital Universitario Ramón y Cajal), Daniel González‐Nieto(Cincinnati Children's Hospital Medical Center), Malav Madhu(Cincinnati Children's Hospital Medical Center), Glenn I. Fishman(New York University), Gabriel Ghiaur(Johns Hopkins University), Bhuvana Murali(Cincinnati Children's Hospital Medical Center), Ashley Ficker(Cincinnati Children's Hospital Medical Center), David E. Gutstein(Scripps Research Institute)
Cited by 154
Related Papers
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
|New England Journal of Medicine|2021|1.7k
Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19
|New England Journal of Medicine|2020|1.1k
ST-Segment Elevation in Patients with Covid-19 — A Case Series
|New England Journal of Medicine|2020|858
Conduction Slowing and Sudden Arrhythmic Death in Mice With Cardiac-Restricted Inactivation of Connexin43
|Circulation Research|2001|686
Sudden Cardiac Death Prediction and Prevention
|Circulation|2010|608